Search research articles
Contact Us
Filters
Showing results (151-160 of 203) with videos related to
Page
of 21
Sort By:
Oncogene
|
September 28, 1999
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
J Kleeff, T Ishiwata, H Maruyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer
Z Zhu, H Friess, F F diMola, et al.
Cancer Research
|
June 15, 1993
Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression
H Friess, Y Yamanaka, M Büchler, et al.
International Journal of Cancer
|
August 12, 1998
Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases
H Friess, X Z Guo, P Berberat, et al.
Digestive Diseases and Sciences
|
April 16, 1998
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis
M Ebert, H U Kasper, S Hernberg, et al.
World Journal of Surgery
|
October 8, 1999
Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3
H Friess, A Fukuda, W H Tang, et al.
International Journal of Cancer
|
July 17, 1996
Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition
R L Baldwin, H Friess, M Yokoyama, et al.
Cancer Research
|
July 17, 2001
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells
K Matsuda, H Maruyama, F Guo, et al.
International Journal of Cancer
|
April 6, 2001
Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo
J Luo, P Guo, K Matsuda, et al.
The American Journal of Pathology
|
January 1, 1994
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis
H Friess, Y Yamanaka, M Büchler, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 203) with videos related to
Sort By:
Page
of 21
Oncogene
|
September 28, 1999
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
J Kleeff, T Ishiwata, H Maruyama, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer
Z Zhu, H Friess, F F diMola, et al.
Cancer Research
|
June 15, 1993
Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression
H Friess, Y Yamanaka, M Büchler, et al.
International Journal of Cancer
|
August 12, 1998
Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases
H Friess, X Z Guo, P Berberat, et al.
Digestive Diseases and Sciences
|
April 16, 1998
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis
M Ebert, H U Kasper, S Hernberg, et al.
World Journal of Surgery
|
October 8, 1999
Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3
H Friess, A Fukuda, W H Tang, et al.
International Journal of Cancer
|
July 17, 1996
Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition
R L Baldwin, H Friess, M Yokoyama, et al.
Cancer Research
|
July 17, 2001
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells
K Matsuda, H Maruyama, F Guo, et al.
International Journal of Cancer
|
April 6, 2001
Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo
J Luo, P Guo, K Matsuda, et al.
The American Journal of Pathology
|
January 1, 1994
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis
H Friess, Y Yamanaka, M Büchler, et al.
Page
of 21